logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Onl Therapeutics Appoints Penny Fleck As Chief Development Officer

Jan 08, 2025•11 months ago

Position

Chief Development Officer

Company

ONL Therapeutics

Penny Fleck
Ann ArborBiopharmaHealth Care

Description

ONL Therapeutics, Inc announced the appointment of Penny Fleck as chief development officer. In her new role, Ms Fleck will lead the development activities for the company’s lead asset, ONL1204 Ophthalmic Solution.

Company Information

Company

ONL Therapeutics

Location

524 S. Main St

Ann Arbor, Michigan, United States

About

ONL Therapeutics (ONL) is a clinical-stage biopharmaceutical company committed to developing first-in-class therapeutics to protect and improve the vision of patients with retinal disease. By advancing a breakthrough technology designed to protect key retinal cells from Fas-mediated cell death, ONL is pioneering a new approach to preserving vision.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months